story of the week
Levetiracetam vs Fosphenytoin as a Second-Line Drug After Diazepam Therapy for Adult Convulsive Status Epilepticus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial
J. Neurol. Neurosurg. Psychiatr. 2022 Oct 07;[EPub Ahead of Print], K Nakamura, A Marushima, Y Takahashi, M Mochizuki, A Kimura, Y Fukuda, M Asami, H Nakamoto, S Egawa, J Kaneko, K Unemoto, Y Kondo, C Yonekawa, M Uchida, E Hoshiyama, T Yamada, K Maruo, E Ishikawa, Y Matsumaru, Y InoueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.